← All trials
NCT06907290
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 25, 2025
- Primary completion
- Jun 30, 2027
- Completion date
- Jun 30, 2028
- First posted
- Apr 2, 2025
- Last posted
- Nov 17, 2025
- Enrollment
- 150
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Bluejay Therapeutics, Inc.Lead sponsor
- Bluejay Therapeutics, Inc.Official
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.